Michael P. Lisanti
Affiliations: | 2006- | Yeshiva University, New York, NY, United States | |
| 2009- | Thomas Jefferson University, Philadelphia, PA, United States | ||
| 2012- | University of Salford, UK |
Area:
Metabolism, Breast Cancer, Cell Biology, Stem Cells, Drug DiscoveryWebsite:
https://www.salford.ac.uk/environment-life-sciences/our-staff/els-academics/michael-lisantiGoogle:
"Michael Lisanti"Bio:
https://scholar.google.com/citations?user=R_7BALYAAAAJ&hl=en
http://cornellcelldevbiology.com/boulan/people.html#sthash.faB2YyDQ.dpbs
Mean distance: 3981.3
Parents
Sign in to add mentor| Enrique Rodriguez-Boulan | grad student | 1991 | Cornell (Cell Biology Tree) | |
| (Glycophospholipid membrane anchoring functions : as an apical targeting signal in polarized epithelial cells.) | ||||
Children
Sign in to add trainee| Jeffrey A. Engelman | grad student | 2000 | Yeshiva University |
| Hyangkyu Lee | grad student | 2002 | Yeshiva University |
| Amnon Schlegel | grad student | 2002 | Yeshiva University |
| Babak Razani | grad student | 2003 | Yeshiva University |
| William E. Schubert | grad student | 2003 | Yeshiva University |
| Terence M. Williams | grad student | 2004 | Yeshiva University |
| Scott E. Woodman | grad student | 2004 | Yeshiva University |
| Freddy A. Medina | grad student | 2006 | Yeshiva University |
| Shana Marmon | grad student | 2007 | Yeshiva University |
| Shengwen Li | post-doc | 1994-1997 | University of Salford |
| Philippe G. Frank | post-doc | 1998-2006 | Yeshiva University (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wolfe AR, Cui T, Baie S, et al. (2024) Nutrient scavenging-fueled growth in pancreatic cancer depends on caveolae-mediated endocytosis under nutrient-deprived conditions. Science Advances. 10: eadj3551 |
| Ózsvári B, Magalhães LG, Latimer J, et al. (2020) A Myristoyl Amide Derivative of Doxycycline Potently Targets Cancer Stem Cells (CSCs) and Prevents Spontaneous Metastasis, Without Retaining Antibiotic Activity. Frontiers in Oncology. 10: 1528 |
| Chen K, Jiao X, Ashton A, et al. (2020) The membrane-associated form of cyclin D1 enhances cellular invasion. Oncogenesis. 9: 83 |
| Brindisi M, Fiorillo M, Frattaruolo L, et al. (2020) Cholesterol and Mevalonate: Two Metabolites Involved in Breast Cancer Progression and Drug Resistance through the ERRα Pathway. Cells. 9 |
| Fiorillo M, Tóth F, Brindisi M, et al. (2020) Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production. Cells. 9 |
| Volpari T, De Santis F, Bracken AP, et al. (2019) Anticancer innovative therapy: Highlights from the ninth annual meeting. Cytokine & Growth Factor Reviews. 51: 1-9 |
| Sivalingam VN, Latif A, Kitson S, et al. (2019) Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin. British Journal of Cancer |
| Pellegrino M, Rizza P, Donà A, et al. (2019) FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer. Cancers. 11 |
| Frattaruolo L, Fiorillo M, Brindisi M, et al. (2019) Thioalbamide, A Thioamidated Peptide from , Affects Tumor Growth and Stemness by Inducing Metabolic Dysfunction and Oxidative Stress. Cells. 8 |
| De Francesco EM, Ózsvári B, Sotgia F, et al. (2019) Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine). Frontiers in Oncology. 9: 615 |